#NeurodegenerativeDisease
LightNews LightNews
alsnewstoday.bsky.social
A new approach emerges: https://bit.ly/45gT6hs

A first in human trial is now underway for NRG5051, an experimental therapy designed to protect mitochondria and potentially slow disease progression in ALS and Parkinson’s.

#ALSNewsToday #ClinicalTrials #NeurodegenerativeDisease #Bionews #Hope
Graphic on ALS news: New drug NRG5051 is being tested in Europe for ALS and Parkinson’s, focusing on protecting mitochondria to slow disease progression.
January 15, 2026 at 3:15 PM
alsnewstoday.bsky.social
New ALS research: https://bit.ly/4qg1JkM

APRTX-003 is an experimental RNA based therapy designed to reduce MMP 9, an enzyme associated with nerve cell damage.

#ALSNewsToday #ALSResearch #ALSScience #NeurodegenerativeDisease #RareDiseaseNews #Bionews
"The Latest ALS News: APRTX-003 is an experimental RNA therapy for ALS, targeting MMP 9 enzyme to reduce nerve cell damage. Preclinical trials ongoing."
January 9, 2026 at 8:02 PM
medcomm.bsky.social
#Review in #MedComm
Neurotransmitters and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets doi.org/10.1002/mco2...

#cancer #InflammatoryDisorder #NeurodegenerativeDisease #neurotransmitter #CNS
Neurotransmitters and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets
Role of neurotransmitters in multiple pathological processes. Various neurotransmitters, including ACh, EPI, NE, 5-HT, histamine, DA, glutamate, GABA, and neuropeptides participate in regulating key ...
doi.org
December 26, 2025 at 5:41 AM
castltrastondrs.bsky.social
- Modulation of glial metabolic pathways (e.g., glycolysis, oxidative phosphorylation, fatty acid metabolism) can alter effector functions & outcomes in #neurodegenerativedisease models .
December 20, 2025 at 4:49 AM
alsnewstoday.bsky.social
New ALS research insight: https://bit.ly/3MvvhvR

A new study suggests that patterns of genetic activity in blood may help detect ALS earlier and even offer clues about survival.

#ALS #ALSResearch #NeurodegenerativeDisease #RareDiseaseResearch #ALSNewsToday #Bionews
New study shows blood genetic activity may help detect ALS and predict survival. Source: ALS News Today.
December 15, 2025 at 8:12 PM
alsnewstoday.bsky.social
Follow This Update: https://bit.ly/4rRASfT

PrimeC is moving closer to an approval request after early findings suggested it may help slow the progression of ALS.

#ALS #ALSAwareness #NeurodegenerativeDisease #Bionews #ALSNewsToday
PrimeC is being prepared for formal approval as an ALS treatment, with early studies showing potential to slow symptom progression.
December 11, 2025 at 7:04 PM
neurodegeneration.bsky.social
The Intricate Role of Caspase-6 and Death Receptor-6 in Neurodegenerative Diseases.

https://pubmed.ncbi.nlm.nih.gov/41335291/

#neurodegeneration #neurodegenerativedisease
December 3, 2025 at 9:37 PM
giuliompasinetti.bsky.social
Large population analysis by Min Xie, Pascal Geldsetzer, et al. @stanforduniversity.bsky.social strengthens growing evidence that viral infections may play an important and previously underappreciated role in #NeurodegenerativeDisease. Learn More @cellpress.bsky.social 👉 www.cell.com/cell/fulltex...
December 3, 2025 at 1:41 PM
alsnewstoday.bsky.social
Explore new ALS research: https://bit.ly/3JHDVGx

Two companies are partnering on a potential new approach that aims to address TDP-43, a toxic protein involved in most ALS cases and many cases of FTD.

#ALSNewsToday #ALSResearch #FTD #TDP43 #NeurodegenerativeDisease #ALSCommunity #Bionews
Graphic titled "ALS News" featuring a megaphone icon. The text discusses two companies collaborating on TDP-43 protein molecules linked to ALS and dementia. The challenge is relocating TDP-43 without hindering its function, aiming to prevent cell dysfunction and disease progression.
November 17, 2025 at 8:02 PM
medcomm.bsky.social
#Article in #MedComm_Oncology

Parkinson's Disease and Cancer: Mechanistic Insights and Therapeutic Opportunities From Cancer Neuroscience doi.org/10.1002/mog2...

#cancer #CancerNeuroscience #gliomas #NeurodegenerativeDisease #PD #Therapeutic #Neuroscience
November 7, 2025 at 8:07 AM
bcmfromthelabs.bsky.social
"Congratulations Joshua Robert for your award at the #Alzheimer’s & #Dementia Research Symposium of Southeast Texas in our lab's work on #AI-driven fMRI #neuromodulation for #neurodegenerativeDisease:"
@dorinapapageorgiou.bsky.social @bcmhouston.bsky.social @bcmneurosci.bsky.social #BCMGradSchool
October 30, 2025 at 4:42 PM
alsnewstoday.bsky.social
Explore promising progress: https://bit.ly/3WppaLi

A new study suggests a simple blood test may one day help diagnose ALS faster and even predict how quickly it will progress.

#ALSResearch #ALSNewsToday #ALSBiomarker #NeurodegenerativeDisease #Bionews
Illustration of a hand holding a blood vial, with a cross-section of a blood vessel showing DNA fragments. Text highlights a blood test for diagnosing and predicting ALS progression.
October 27, 2025 at 12:52 PM
abfbrain.bsky.social
#ALS and #FTD have much in common, with overlapping genetic characteristics, causes, and protein deposits in nerve cells. We fund research across the entire spectrum of brain disease: discoveries that lead to a cure for one could lead to cures for others. #NeurodegenerativeDisease
October 17, 2025 at 8:02 PM
alsnewstoday.bsky.social
New ALS Drug in Development: https://bit.ly/47tX2N5

Eikonizo Therapeutics’ experimental oral therapy, EKZ-102, is expected to begin clinical testing in 2026.

#ALSNewsToday #Bionews #ALSResearch #ALSTreatment #EikonizoTherapeutics #NeurodegenerativeDisease #ALSNewsToday
Graphic summarizing a study on EKZ-438, a precursor to Eikonizo’s EKZ-102, showing potential benefits for ALS treatment by reducing abnormal protein buildup and improving motor neuron survival.
October 16, 2025 at 8:24 PM
irat1onal.bsky.social
From Patient To Genetics Research Pioneer - Christian Maugee - PhD Candidate, University of Florida joins me on Progress, Potential, And Possibilities #FriedrichsAtaxia #NeurodegenerativeDisease #Genetics #Genomics #MolecularBiology www.youtube.com/watch?v=BDxL...
Christian Maugee - PhD Candidate, University Of Florida - From Patient To Genetics Research Pioneer
YouTube video by Progress, Potential, and Possibilities
www.youtube.com
October 15, 2025 at 10:27 PM
epilepsia-open.bsky.social
Late-onset epilepsy of unknown etiology (LOEU) is less likely to receive ASM polytherapy than acquired lesional late-onset epilepsy (LOE).
doi.org/10.1002/epi4...

#epilepsy #ilae #epilepsiaOpen #Alzheimersdisease #cerebrovasculardisease #elderly #lateonsetepilepsy #neurodegenerativedisease
October 15, 2025 at 8:00 PM
pharmaphorum.bsky.social
#uniQure's #genetherapy for #Huntington's has hit the mark in a clinical trial, raising hopes of the first treatment for the devastating #neurodegenerativedisease.

pharmaphorum.com/news/joy-uni...
Joy as uniQure Huntington's therapy clears pivotal trial
uniQure's gene therapy AMT-130 has cleared a trial in Huntington's, setting up filings and raising the prospect of a first treatment for the disease
pharmaphorum.com
September 24, 2025 at 4:36 PM
dennyc69.bsky.social
When discussing Parkinson’s disease, the audience often falls into three groups: the curious, the afflicted, and the scholarly, each with different needs, perspectives, and questions #parkinson #movementdisorders #parkinsonawareness
#neurodegenerativedisease   #ourworldinwordsandfilm
September 23, 2025 at 5:40 PM
alsnewstoday.bsky.social
Keep your mind engaged: https://bit.ly/46rjOUl

Keeping the mind active with ALS is about finding joy in activities that spark your curiosity, creativity, or connection. At the same time, adapt around your comfort and physical needs.

#ALS #EndALS #NeurodegenerativeDisease #ALSNewsToday #Bionews
Cognitive engagement tips for ALS: Puzzles, reading, creative expression, learning, social interaction, adapt as needs change.
September 19, 2025 at 11:31 AM
dennyc69.bsky.social
When discussing Parkinson’s disease, the audience often falls into three groups: the curious, the afflicted, and the scholarly, each with different needs, perspectives, and questions #parkinson #movementdisorders #parkinsonawareness
#neurodegenerativedisease   #ourworldinwordsandfilm
September 14, 2025 at 4:02 PM
dennyc69.bsky.social
When discussing Parkinson’s disease, the audience often falls into three groups: the curious, the afflicted, and the scholarly, each with different needs, perspectives, and questions #parkinson #movementdisorders #parkinsonawareness
# neurodegenerativedisease  #Our World in Words and Film
September 13, 2025 at 9:01 PM
equestrian34.bsky.social
Secondary Progressive Multiple Sclerosis

Fighting the good fight. Continuing to fight my own immune and nervous system that is destroying everything quicker than expected. Don’t mind me as I throw around some fuckity fucks!

#Chronicillness
#AutoimmuneDisease
#Neurodegenerativedisease
#MS
#SPMS
September 6, 2025 at 1:57 PM
plastictulip3.bsky.social
they would turn in their graves
-this week about my great-great-grandmother Rose

#census #familyhistory #genealogy #women #mothers #grandmothers #daughters #descendants #ancestors #19thcentury #maternalmortality #tragedy #childbirth #neurodegenerativedisease #resist
they would turn in their graves
Margerett Rosallia (Snyder) Harter Margerett Rosallia Snyder, my 2 nd   great-grandmother, was born in 1865 in Indiana, the eldest child of ...
theywouldturnintheirgraves.blogspot.com
August 2, 2025 at 7:42 PM
plosbiology.org
How does cerebral #BloodPerfusion map onto micro-, meso- & macro-scale brain structure? @asafarahani.bsky.social @misicbata.bsky.social &co characterize blood perfusion in the #HumanBrain, revealing how it changes with age & in #NeurodegenerativeDisease @plosbiology.org 🧪 plos.io/46AEURS
Normative blood perfusion map on lateral and medial views of the inflated and 2D flat cortical surfaces (fsLR). Borders and areal names of the multi-modal Glasser parcellation are overlaid on the flat surface. The figure highlights the non-uniform distribution of perfusion scores across the cortex, with areas that have sharp gradient compared to their underlying perfusion score levels (e.g., LIPv and MT/MST).
July 31, 2025 at 5:09 PM
plosbiology.org
How does cerebral #BloodPerfusion map onto micro-, meso- & macro-scale brain structure? @asafarahani.bsky.social @misicbata.bsky.social &co characterize blood perfusion in the #HumanBrain, revealing how it changes with age & in #NeurodegenerativeDisease @plosbiology.org 🧪 plos.io/46AEURS
Normative blood perfusion map on lateral and medial views of the inflated and 2D flat cortical surfaces (fsLR). Borders and areal names of the multi-modal Glasser parcellation are overlaid on the flat surface. The figure highlights the non-uniform distribution of perfusion scores across the cortex, with areas that have sharp gradient compared to their underlying perfusion score levels (e.g., LIPv and MT/MST).
July 31, 2025 at 1:54 PM